Orthopedic Surgery Doctors in West Burlington, IA Accepting Medicare

5 Orthopedic Surgery doctors found. Showing 1 - 5

Giselle Joan Tan, M.D. Orthopaedic Surgery - Foot and Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 1401 W Agency Rd, West Burlington, IA 52655 Phone: 319-768-4970

Dr. Scott M Gleason, D.O., MSC. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1401 W Agency Rd, West Burlington, IA 52655 Phone: 319-768-4970    Fax: 319-768-4975

Jerry Leverne Jochims, M.D. Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1225 S Gear Ave, Suite 159, West Burlington, IA 52655 Phone: 319-752-4553    Fax: 319-752-7215

Craig Alan Bottke, M.D. Orthopaedic Surgery - Hand Surgery Medicare: Accepting Medicare Assignments Practice Location: 1401 W Agency Rd, West Burlington, IA 52655 Phone: 319-768-4970

Robert Douglas Foster, MD Orthopaedic Surgery - Orthopaedic Surgery of the Spine Medicare: Accepting Medicare Assignments Practice Location: 1225 S Gear Ave, Ste. 254, West Burlington, IA 52655 Phone: 319-768-3320    Fax: 319-768-3460

News Archive

Studies show new massage and physical therapy technique increased pregnancy rates in infertile women

The researchers reported that the Wurn Technique(R) (patent pending) is highly effective at increasing fertility in both natural conception and in vitro fertilization (IVF). The therapy uses neither drugs nor surgery.

Scientists create method for mapping genome-wide DNA damage caused by chemical carcinogen

Scientists have known for decades that smoking cigarettes causes DNA damage, which leads to lung cancer. Now, for the first time, UNC School of Medicine scientists created a method for effectively mapping that DNA damage at high resolution across the genome.

NIH awards $5.59 million research grants to prevent and treat cerebral palsy

The National Institutes of Health is supporting a Wayne State University School of Medicine physician-researcher's work at preventing and treating cerebral palsy in the form of two new five-year R01 grants worth a collective $5.59 million.

IQWiG dossier assessment finds added benefit of afatinib in patients with certain mutations

Afatinib (trade name: Giotrif) has been approved since September 2013 for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating EGF receptor mutations who have not been treated with an EGF receptor tyrosine-kinase inhibitor (EGFR TKI).

Read more Medical News

› Verified 1 days ago